Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Helena Dankova"'
Autor:
Monika Cahova, Martin Kveton, Vojtech Petr, David Funda, Helena Dankova, Ondrej Viklicky, Petra Hruba
Publikováno v:
Kidney & Blood Pressure Research, Vol 46, Iss 2, Pp 245-249 (2021)
Background: Preclinical studies suggested that pharmacological inhibition of the renin-angiotensin-aldosterone system (RAAS) by ACE inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) may increase local angiotensin-converting enzyme 2 (ACE2
Externí odkaz:
https://doaj.org/article/b3c894109cef4ec2b5a5ebce72de3174
Autor:
Denisa Erhartova, Monika Cahova, Helena Dankova, Marie Heczkova, Irena Mikova, Eva Sticova, Julius Spicak, Ondrej Seda, Pavel Trunecka
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224820 (2019)
BACKGROUND & AIMS:MiR-33a has emerged as a critical regulator of lipid homeostasis in the liver. Genetic deficiency of miR-33a aggravates liver steatosis in a preclinical model of non-alcoholic fatty liver disease (NAFLD), and relative expression of
Externí odkaz:
https://doaj.org/article/329dee9fe47441ee85f06280580b2deb
Autor:
Vit Kosek, Marie Heczkova, Frantisek Novak, Eva Meisnerova, Olga Novákova, Jaroslav Zelenka, Kamila Bechynska, Nikola Vrzacova, Jiri Suttnar, Alzbeta Hlavackova, Helena Dankova, Miriam Bratova, Nikola Daskova, Hana Malinska, Olena Oliyarnyk, Petr Wohl, Hana Bastova, Jana Hajslova, Monika Cahova
Publikováno v:
Nutrients, Vol 12, Iss 8, p 2351 (2020)
Omega-3 polyunsaturated fatty acids (ω-3PUFAs) are introduced into parenteral nutrition (PN) as hepatoprotective but may be susceptible to the lipid peroxidation while olive oil (OO) is declared more peroxidation resistant. We aimed to estimate how
Externí odkaz:
https://doaj.org/article/e3e543c3592b49c99235e66147484bf4
Autor:
Zuzana Papackova, Marie Heczkova, Helena Dankova, Eva Sticova, Alena Lodererova, Lenka Bartonova, Martin Poruba, Monika Cahova
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191353 (2018)
Acetaminophen or paracetamol (APAP) overdose is a common cause of liver injury. Silymarin (SLM) is a hepatoprotective agent widely used for treating liver injury of different origin. In order to evaluate the possible beneficial effects of SLM, Balb/c
Externí odkaz:
https://doaj.org/article/eb80a6a688fb4786af49f961c3e945ba
Autor:
Monika Cahova, Helena Dankova, Eliska Palenickova, Zuzana Papackova, Radko Komers, Jana Zdychova, Eva Sticova, Ludmila Kazdova
Publikováno v:
Biochemistry Research International, Vol 2012 (2012)
We tested the hypothesis that TAG accumulation in the liver induced by short-term high-fat diet (HFD) in rats leads to the dysregulation of endogenous TAG degradation by lysosomal lipase (LIPA) via lysosomal pathway and is causally linked with the on
Externí odkaz:
https://doaj.org/article/7ed24344729042418f9f135362730f23
Publikováno v:
Journal of Nutrition and Metabolism, Vol 2012 (2012)
Aims. To determine the effect of two different diets (high-sucrose (HS) and high-fat (HF)) on the main metabolic pathways potentially contributing to the development of steatosis: (1) activity of the liver lysosomal and heparin-releasable lipases; (2
Externí odkaz:
https://doaj.org/article/9e7fc9c5b17943e092fb3d193c744d6a
Autor:
David P. Funda, Vojtech Petr, Ondrej Viklicky, Monika Cahova, Helena Dankova, Martin Kveton, Petra Hruba
Publikováno v:
Kidney & Blood Pressure Research, Vol 46, Iss 2, Pp 245-249 (2021)
Kidney & Blood Pressure Research
Kidney & Blood Pressure Research
Background: Preclinical studies suggested that pharmacological inhibition of the renin-angiotensin-aldosterone system (RAAS) by ACE inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) may increase local angiotensin-converting enzyme 2 (ACE2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8007f25c843e61880cfaa9bee3f560
https://www.karger.com/Article/FullText/513710
https://www.karger.com/Article/FullText/513710
Autor:
František Novák, Hana Bastova, Jana Hajslova, Monika Cahova, Jaroslav Zelenka, Hana Malinska, Eva Meisnerova, Miriam Bratova, Nikola Vrzacova, Helena Dankova, Vit Kosek, Kamila Bechynska, Petr Wohl, Olga Novakova, Alzbeta Hlavackova, Nikola Daskova, Jiri Suttnar, Marie Heczkova, Olena Oliyarnyk
Publikováno v:
Nutrients
Volume 12
Issue 8
Nutrients, Vol 12, Iss 2351, p 2351 (2020)
Volume 12
Issue 8
Nutrients, Vol 12, Iss 2351, p 2351 (2020)
Omega-3 polyunsaturated fatty acids (&omega
3PUFAs) are introduced into parenteral nutrition (PN) as hepatoprotective but may be susceptible to the lipid peroxidation while olive oil (OO) is declared more peroxidation resistant. We aimed to esti
3PUFAs) are introduced into parenteral nutrition (PN) as hepatoprotective but may be susceptible to the lipid peroxidation while olive oil (OO) is declared more peroxidation resistant. We aimed to esti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afdba2a9173d9437689c222881d4f9d0
Autor:
Nikola Daskova, Kamila Bechynska, Miriam Bratova, Marie Heczkova, Nikola Vrzáčková, Jiri Suttnar, Lenka Bartonova, Jaroslav Zelenka, Helena Dankova, Alzbeta Hlavackova, Zuzana Berková, Katerina Podzimkova, Karel Harant, Jana Hajslova, Vit Kosek, Radislav Sedlacek, Monika Cahova
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Parenteral nutrition (PN) is often associated with the deterioration of liver functions (PNALD). Omega-3 polyunsaturated fatty acids (PUFA) were reported to alleviate PNALD but the underlying mechanisms have not been fully unraveled yet. Using omics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0874f4baa1762f7e948392dff24fd7f3
http://europepmc.org/articles/PMC6910966
http://europepmc.org/articles/PMC6910966
Autor:
Helena Dankova, Eva Sticova, Ondrej Seda, Pavel Trunecka, Denisa Erhartová, Monika Cahova, Marie Heczkova, Irena Míková, Julius Spicak
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 11, p e0224820 (2019)
PLoS ONE, Vol 14, Iss 11, p e0224820 (2019)
Background & aims MiR-33a has emerged as a critical regulator of lipid homeostasis in the liver. Genetic deficiency of miR-33a aggravates liver steatosis in a preclinical model of non-alcoholic fatty liver disease (NAFLD), and relative expression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b6c29ebac7cbf867463a925d887f8e
http://europepmc.org/articles/PMC6839850
http://europepmc.org/articles/PMC6839850